Autolus Therapeutics PLC Sponsored ADR

AUTL Healthcare Biotechnology

In the quarter to June 2026, revenue grew 118.4%, EPS grew 16.7% and free cash flow grew 67.6%, each against the same quarter a year earlier.

1.63 0.11 −6.32%
Market cap
$463.1M
P/E
0.0×
Fwd P/E
−1.7×
Dividend yield
—
F-score
3/9
Altman Z
−3.17
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '17 Sep '18 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
137.07 247.09 217.56 211.43 154.09 310.68 382.76 240.34 589.45 302.21
Receivables
4.73 — 9.26 30.52 29.69 26.18 28.94 — 0.02 24.02
Inventory
— — — — — — — — 4.14 33.21
Other current assets
5.41 — — — — — — — — —
Total current assets
5.41 259.28 232.97 249.26 196.98 346.95 425.77 275.30 660.93 435.92
Property, Plant, Equpment (Net)
6.18 13.53 19.97 28.16 38.05 33.54 35.21 34.86 49.55 63.56
Goodwill and Intangible Assets (Total)
0.00 0.40 0.40 0.25 0.16 0.07 — — 12.37 19.81
Long Term Assets (Tax, Deferred)
— — — 0.41 1.75 1.83 2.08 3.06 3.24 3.56
Long-term assets (Other)
— — 1.28 2.04 2.63 2.04 1.83 0.98 0.96 1.03
Total non-current assets
— 13.93 21.24 54.28 97.25 58.61 64.50 100.08 121.80 153.15
Total Assets
5.41 273.21 254.21 303.53 294.24 405.56 490.27 375.38 782.73 589.07
Accounts Payable
— 3.04 2.02 1.08 2.26 0.43 0.53 0.10 1.97 3.08
Accrued Expenses
— 14.10 19.05 21.40 27.78 23.67 40.80 39.58 52.28 55.79
Current Part of Capital Lease
0.00 — — 2.51 — — — — — —
Current Part of Taxes to Pay
0.00 — — — — — — — — —
Other current liabilities
5.03 — 17.14 22.08 27.78 23.67 40.80 — 3.50 10.00
Total current liabilities
5.03 17.14 21.08 24.98 33.63 28.55 46.37 44.74 60.74 73.44
Long Term Debt (Total)
— 0.22 0.21 23.71 50.57 16.55 19.22 47.91 49.63 —
Non-current Revenue (Deferred)
0.00 — — — — — — — — —
Minority Interests
0.00 — — — — — — — — —
Non-current Liabilities (Other)
1.03 0.38 0.29 — 0.00 47.14 126.02 171.26 245.03 270.68
Total non-current liabilities
— 0.60 0.49 23.71 50.57 63.69 145.23 219.17 294.66 337.50
Total liabilities
6.06 17.74 21.57 48.69 84.21 92.24 191.60 263.91 355.40 410.94
Additional Paid In Capital
— 357.92 361.31 500.56 595.02 843.11 1,007.63 1,018.90 1,555.59 1,570.11
Preferred Stock (Total)
0.00 — — — — — — — — —
Common Stock (Net)
— 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01
Retained Earnings
(47.90) (92.65) (113.30) (237.15) (379.24) (521.34) (670.18) (878.56) (1,099.22) (1,386.75)
Equity Equivalent
— 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12
Treasury Stock
0.00 — — — — — — — — —
Shareholders Equity (Other)
(3.84) — — — — — — — — —
Common Equity (Total)
(3.84) 255.47 232.64 254.84 210.03 313.32 298.67 111.47 427.33 178.13
Shareholders Equity (Total)
(3.84) 255.47 232.64 254.84 210.03 313.32 298.67 111.47 427.33 178.13
Shareholders Equity and Liabilities (Total)
(3.84) 273.21 254.21 303.53 294.24 405.56 490.27 375.38 782.73 589.07
Shares (Common)
— 40.15 40.15 44.98 52.35 90.91 173.08 174.16 266.13 266.14
Shareholders Equity (Tangible)
5.41 255.07 232.64 254.59 209.87 313.26 298.67 111.47 414.95 158.32
Net Debt
(137.07) (246.87) (217.35) (187.72) (103.51) (294.13) (363.54) (192.42) (539.82) (302.21)
Total Debt
— 0.22 0.21 23.71 50.57 16.55 19.22 47.91 49.63 —

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 28 Sep 2026